Literature DB >> 29194778

A historical perspective on milestones in multiple myeloma research.

Domenico Ribatti1,2.   

Abstract

The first well-documented case of multiple myeloma was reported in 1844 by Samuel Solly. In this article, the author presents a historical review of the disease. In particular, the review is focused on the main steps, including the definition of Bence Jones proteinuria, the characterization of tumoral plasma cells and serum globulins, and the fundamental contribution of Jan Waldenstrom. Finally, treatment of multiple myeloma, as well as the development of new agents, is discussed.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hematology; history of medicine; multiple myeloma; tumor growth

Mesh:

Substances:

Year:  2017        PMID: 29194778     DOI: 10.1111/ejh.13003

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

Review 1.  What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma.

Authors:  Bruno Almeida Costa; Tarek H Mouhieddine; Joshua Richter
Journal:  Target Oncol       Date:  2022-06-30       Impact factor: 4.864

2.  The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling.

Authors:  Antoine David; Simone Zocchi; Alexis Talbot; Caroline Choisy; Ashley Ohnona; Julien Lion; Wendy Cuccuini; Jean Soulier; Bertrand Arnulf; Jean-Christophe Bories; Michele Goodhardt; David Garrick
Journal:  Leukemia       Date:  2020-09-03       Impact factor: 11.528

Review 3.  The role of the bone microenvironment in regulating myeloma residual disease and treatment.

Authors:  Terry G Dadzie; Alanna C Green
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.